126 related articles for article (PubMed ID: 23175469)
1. Myeloid leukemia cells with a B7-2(+) subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands.
Dolen Y; Esendagli G
Eur J Immunol; 2013 Mar; 43(3):747-57. PubMed ID: 23175469
[TBL] [Abstract][Full Text] [Related]
2. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
Tamura H; Dan K; Tamada K; Nakamura K; Shioi Y; Hyodo H; Wang SD; Dong H; Chen L; Ogata K
Clin Cancer Res; 2005 Aug; 11(16):5708-17. PubMed ID: 16115907
[TBL] [Abstract][Full Text] [Related]
3. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.
Karasar P; Esendagli G
Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762
[TBL] [Abstract][Full Text] [Related]
4. Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.
Krönig H; Kremmler L; Haller B; Englert C; Peschel C; Andreesen R; Blank CU
Eur J Haematol; 2014 Mar; 92(3):195-203. PubMed ID: 24175978
[TBL] [Abstract][Full Text] [Related]
5. Human decidual macrophages suppress IFN-γ production by T cells through costimulatory B7-H1:PD-1 signaling in early pregnancy.
Sayama S; Nagamatsu T; Schust DJ; Itaoka N; Ichikawa M; Kawana K; Yamashita T; Kozuma S; Fujii T
J Reprod Immunol; 2013 Dec; 100(2):109-17. PubMed ID: 24045115
[TBL] [Abstract][Full Text] [Related]
6. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells.
Chen C; Qu QX; Huang JA; Zhu YB; Ge Y; Wang Q; Zhang XG
Immunobiology; 2007; 212(3):159-65. PubMed ID: 17412283
[TBL] [Abstract][Full Text] [Related]
7. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
8. Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells.
Vereecque R; Saudemont A; Quesnel B
Leukemia; 2004 Jul; 18(7):1223-30. PubMed ID: 15152266
[TBL] [Abstract][Full Text] [Related]
9. Suppression of IL-22-producing T helper 22 cells by RPE cells via PD-L1/PD-1 interactions.
Sugita S; Kawazoe Y; Imai A; Usui Y; Takahashi M; Mochizuki M
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6926-33. PubMed ID: 24065812
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
Sim JH; Park MJ; Park S; Lee ES
Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
[TBL] [Abstract][Full Text] [Related]
11. Functional exhaustion of CD4
Ozkazanc D; Yoyen-Ermis D; Tavukcuoglu E; Buyukasik Y; Esendagli G
Immunology; 2016 Dec; 149(4):460-471. PubMed ID: 27565576
[TBL] [Abstract][Full Text] [Related]
12. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.
Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L
Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469
[TBL] [Abstract][Full Text] [Related]
13. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.
Oikawa T; Takahashi H; Ishikawa T; Hokari A; Otsuki N; Azuma M; Zeniya M; Tajiri H
Pathol Int; 2007 Aug; 57(8):485-92. PubMed ID: 17610472
[TBL] [Abstract][Full Text] [Related]
15. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
16. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
Li Y; McGowan P; Hellström I; Hellström KE; Chen L
J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
[TBL] [Abstract][Full Text] [Related]
17. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1.
Lauden L; Boukouaci W; Borlado LR; López IP; Sepúlveda P; Tamouza R; Charron D; Al-Daccak R
Circ Res; 2013 Feb; 112(3):451-64. PubMed ID: 23243206
[TBL] [Abstract][Full Text] [Related]
18. B7 costimulation and intracellular indoleamine-2,3-dioxygenase expression in peripheral blood of healthy pregnant and pre-eclamptic women.
Toldi G; Vásárhelyi B; Biró E; Fügedi G; Rigó J; Molvarec A
Am J Reprod Immunol; 2013 Mar; 69(3):264-71. PubMed ID: 23289444
[TBL] [Abstract][Full Text] [Related]
19. Adaptive resistance: a tumor strategy to evade immune attack.
Yao S; Chen L
Eur J Immunol; 2013 Mar; 43(3):576-9. PubMed ID: 23381914
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype.
Creery WD; Diaz-Mitoma F; Filion L; Kumar A
Eur J Immunol; 1996 Jun; 26(6):1273-7. PubMed ID: 8647204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
